Contraline

Contraline is a biotechnology company inventing the future of male contraception. The company is developing two products: ADAM™, an injectable hydrogel implant designed to provide long-lasting, reversible barrier contraception for men without affecting sensation, and NES/T, a daily topical gel that suppresses sperm production reversibly. ADAM successfully completed its first-in-human clinical trial and Contraline holds an exclusive license for NES/T. Contraline's mission is to deliver highly effective, safe, and reversible male contraceptives that fit seamlessly into people's lives.